Navigation Links
Advanced Health Media Acquires Advogent
Date:2/2/2010

BRIDGEWATER, N.J., Feb. 2 /PRNewswire/ -- Advanced Health Media, LLC (AHM), the leading U.S. provider of pharmaceutical sales, marketing and compliance technology and services, announced it has acquired substantially all of the assets of Advogent Group, Inc. (Advogent), a Piscataway, NJ-based provider of marketing services for the pharmaceutical industry. Integration of the companies will begin immediately and headquarters will remain at AHM's Bridgewater, N.J. office. Terms of the agreement were not disclosed.

The addition of Advogent's services and customers expands AHM's market presence and leadership and provides a foundation for ongoing business growth, while offering pharmaceutical industry customers the broadest possible suite of marketing and relationship management services that comply with all federal and state regulations. "This acquisition solidifies AHM's market leadership position in speaker bureau management and marketing communications," said Kevin McMurtry, Founder and CEO of Advanced Health Media. "The combined business will be one of the largest marketing services and technology suppliers in the pharmaceutical industry. Our scale and breadth of services will be a competitive advantage for AHM and its customers."

"We are excited about the integration of these two organizations," said Jeff Brady, President of AHM.  "AHM and Advogent have each established proven track records for exceptional service to their customers.  Our expanded organization has the scale and experience needed to provide our clients the highest levels of service in an increasingly complex promotional environment."  

About Advanced Health Media, LLC

Advanced Health Media (AHM) is the leading U.S. provider of speaker-led meeting logistics, state and federal regulatory compliance technology, thought leader development and medical communications. AHM offers a fully integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, customer relationship management and compliance tracking and reporting systems.  AHM also provides full-service medical communications, including strategic communication strategy, publication planning, scientific meetings and key opinion leader advocacy development. AHM provides services to more than 50 companies in the pharmaceutical sector.

Headquartered in Bridgewater, NJ, with offices in Union and Somerville, NJ, Chesapeake, VA, and Chicago, IL, AHM is the parent company of AHM Solutions, Centeon Solutions, Embryon, LLC, Cogenix, LLC, ProMedix, LLC, InsiteResearch, LLC and Ephikacy, LLC. For more information, please visit the AHM Web site at www.ahmdirect.com.

About Advogent Group, Inc.

Advogent Group, Inc. creates, delivers, and manages compliant communications and strategic solutions and services for pharmaceutical, biotechnology, and medical device companies. The company offers strategic publication services; and healthcare communications, including advocacy development and management, message delivery and management, and content creation. It also provides event management and logistics, and compliant data systems. The company was founded in 2007 and is headquartered in Piscataway, New Jersey. Advogent Group, Inc. is a former subsidiary of Cardinal Health, Inc.

SOURCE Advanced Health Media, LLC

RELATED LINKS
http://www.ahmdirect.com

'/>"/>

SOURCE Advanced Health Media, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):